Emerging role of ficolins in autoimmune diseases

[Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major ro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 2021-01, Vol.163, p.105266-105266, Article 105266
Hauptverfasser: Wang, Peng, Wu, Qian, Shuai, Zong-Wen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105266
container_issue
container_start_page 105266
container_title Pharmacological research
container_volume 163
creator Wang, Peng
Wu, Qian
Shuai, Zong-Wen
description [Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs). Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.
doi_str_mv 10.1016/j.phrs.2020.105266
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2456430699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661820315747</els_id><sourcerecordid>2456430699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EoqXwAhxQjlxSPHHsxhIXVJVFqsQFzpaXSXGVpdgJEm9PohSOnGbRN780HyHXQJdAQdztl4ePEJcZzcYFz4Q4IXOgUqQAhTgd-5ylQkAxIxcx7imlMgd6TmaMQbbifDUndFNj2Plml4S2wqQtk9LbtvJNTHyT6L5rfV33DSbOR9QR4yU5K3UV8epYF-T9cfO2fk63r08v64dtahkXXZobaaQzuROFKZmQIDkYwSwDK7XghaGCoubDYEwBunRFbkE6MBRNVkLOFuR2yj2E9rPH2KnaR4tVpRts-6iynIucUSHlgGYTakMbY8BSHYKvdfhWQNVoSu3VaEqNptRkaji6Oeb3pkb3d_KrZgDuJwCHL788BhWtx8ai8wFtp1zr_8v_AXMVeT4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2456430699</pqid></control><display><type>article</type><title>Emerging role of ficolins in autoimmune diseases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</creator><creatorcontrib>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</creatorcontrib><description>[Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs). Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2020.105266</identifier><identifier>PMID: 33127557</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Autoimmune diseases ; Autoimmune Diseases - drug therapy ; Autoimmune Diseases - immunology ; Autoimmunity ; Ficolins ; Humans ; Lectins - chemistry ; Lectins - genetics ; Lectins - immunology</subject><ispartof>Pharmacological research, 2021-01, Vol.163, p.105266-105266, Article 105266</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</citedby><cites>FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</cites><orcidid>0000-0002-5708-6509</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phrs.2020.105266$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33127557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Shuai, Zong-Wen</creatorcontrib><title>Emerging role of ficolins in autoimmune diseases</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs). Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</description><subject>Animals</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmunity</subject><subject>Ficolins</subject><subject>Humans</subject><subject>Lectins - chemistry</subject><subject>Lectins - genetics</subject><subject>Lectins - immunology</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EoqXwAhxQjlxSPHHsxhIXVJVFqsQFzpaXSXGVpdgJEm9PohSOnGbRN780HyHXQJdAQdztl4ePEJcZzcYFz4Q4IXOgUqQAhTgd-5ylQkAxIxcx7imlMgd6TmaMQbbifDUndFNj2Plml4S2wqQtk9LbtvJNTHyT6L5rfV33DSbOR9QR4yU5K3UV8epYF-T9cfO2fk63r08v64dtahkXXZobaaQzuROFKZmQIDkYwSwDK7XghaGCoubDYEwBunRFbkE6MBRNVkLOFuR2yj2E9rPH2KnaR4tVpRts-6iynIucUSHlgGYTakMbY8BSHYKvdfhWQNVoSu3VaEqNptRkaji6Oeb3pkb3d_KrZgDuJwCHL788BhWtx8ai8wFtp1zr_8v_AXMVeT4</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Wang, Peng</creator><creator>Wu, Qian</creator><creator>Shuai, Zong-Wen</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5708-6509</orcidid></search><sort><creationdate>202101</creationdate><title>Emerging role of ficolins in autoimmune diseases</title><author>Wang, Peng ; Wu, Qian ; Shuai, Zong-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-4b9b9db4d68bf3691951b63c31c9a658b060ea5c9abb81afd84c19d1b0eb2f143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmunity</topic><topic>Ficolins</topic><topic>Humans</topic><topic>Lectins - chemistry</topic><topic>Lectins - genetics</topic><topic>Lectins - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Shuai, Zong-Wen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Peng</au><au>Wu, Qian</au><au>Shuai, Zong-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerging role of ficolins in autoimmune diseases</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2021-01</date><risdate>2021</risdate><volume>163</volume><spage>105266</spage><epage>105266</epage><pages>105266-105266</pages><artnum>105266</artnum><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted] •Ficolins form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation.•Ficolins regulate homeostasis by mediating immune responses of opsonization, phagocytosis and cytokine production.•Emerging evidence has suggested the major role of ficolins in the onset and development of autoimmune diseases (ADs). Ficolins are pattern-recognition molecules (PRMs) that could form complexes with mannose-binding lectin-associated serine proteases (MASPs) to trigger complement activation via the lectin pathway, thereby mediating a series of immune responses including opsonization, phagocytosis and cytokine production. In the past few decades, accumulating evidence have suggested that ficolins play a major role in the onset and development of several autoimmune diseases (ADs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), Type 1 diabetes (T1D), inflammatory bowel disease (IBD), etc. In this review, we synthesized previous literatures and recent advances to elucidate the immunological regulations of ficolins and discuss the potential diagnostic ability of ficolins in ADs, as well as giving an insight into the future therapeutic options for ficolins in ADs.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33127557</pmid><doi>10.1016/j.phrs.2020.105266</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5708-6509</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1043-6618
ispartof Pharmacological research, 2021-01, Vol.163, p.105266-105266, Article 105266
issn 1043-6618
1096-1186
language eng
recordid cdi_proquest_miscellaneous_2456430699
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Autoimmune diseases
Autoimmune Diseases - drug therapy
Autoimmune Diseases - immunology
Autoimmunity
Ficolins
Humans
Lectins - chemistry
Lectins - genetics
Lectins - immunology
title Emerging role of ficolins in autoimmune diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A08%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerging%20role%20of%20ficolins%20in%20autoimmune%20diseases&rft.jtitle=Pharmacological%20research&rft.au=Wang,%20Peng&rft.date=2021-01&rft.volume=163&rft.spage=105266&rft.epage=105266&rft.pages=105266-105266&rft.artnum=105266&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2020.105266&rft_dat=%3Cproquest_cross%3E2456430699%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2456430699&rft_id=info:pmid/33127557&rft_els_id=S1043661820315747&rfr_iscdi=true